Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats

Genetic, molecular and physiological insights into human obesity

(2011) I. Sadaf Farooqi   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Cafeteria Diet Is a Robust Model of Human Metabolic Syndrome With Liver and Adipose Inflammation: Comparison to High-Fat Diet

(2011) Brante P. Sampey et al.   Obesity

Mouse models of the metabolic syndrome

(2010) A. J. Kennedy et al.   Disease Models & Mechanisms

Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome

(2010) Andreas Nygaard Madsen et al.   JOURNAL OF ENDOCRINOLOGY

Lorcaserin—not a new weapon in the battle with appetite

(2010) Jason C. G. Halford   Nature Reviews Endocrinology

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

(2009) Arne Astrup et al.   LANCET

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

(2009) John B Buse et al.   LANCET

Effects of a Novel Y5 Antagonist in Obese Mice: Combination With Food Restriction or Sibutramine

(2008) Satoshi Mashiko et al.   Obesity

Effects of Gastric Bypass and Gastric Banding on Glucose Kinetics and Gut Hormone Release

(2008) Frédérique Rodieux et al.   Obesity

Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats

(2006) Angels Fisas et al.   BRITISH JOURNAL OF PHARMACOLOGY